ArticleAustralasian journal on ageing2026
Improving Osteoporosis Screening in Parkinson's Disease and Related Conditions-Think FRAGILE.
Article in Australasian journal on ageing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesPatients living with Parkinson's disease (PD) and related disorders are at increased risk of osteoporosis and fractures. However, bone health remains under-assessed in clinical practice. The aim of this study was to evaluate whether the FRAGILE tool that we previously developed improved osteoporosis screening and referral practices in a PD and related diseases clinic.
methodsWe performed an audit of 283 outpatient consultation letters evaluating the use of the FRAGILE tool for screening osteoporosis risk.
resultsFollowing implementation of the FRAGILE tool our referral rate for osteoporosis screening improved from 23% to 48% of at-risk patients. Specifically, marked improvements were seen in referrals for patients with osteopenia, falls and fractures, but factors such as osteoporosis-associated medications and medical comorbidities were still often overlooked.
conclusionsOsteoporosis screening referrals improved after introduction of the FRAGILE tool in clinical practice. Further efforts are required to address less overt risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.